GLP-1s May Lead to an Increased Risk of Post-Endoscopy Aspiration Pneumonia by ColoWrap, on May 15, 2024 In a recent large population-based study published in the peer-reviewed Gastroenterology journal, researchers found that glucagon-like peptide-1 receptor agonist (GLP-1RA) medicationssuch as Ozempic and Wegovy that are integrally transforming medications in the management of type 2 diabetes and obesityare associated with a higher risk of post-endoscopy aspiration pneumonia
How should the 12mg blend be stored after reconstitution
Legitimate peptide therapies [like a GLP-1], intended for human use, require medical oversight, and must be dispensed through licensed pharmacies
For someone at a healthy weight without diabetes, GLP-1 medications come with real costs: gastrointestinal side effects, monthly expense, the time and attention of follow-up, and the small risks that come with any medication
First, Effects of the KD on Liver Physiology and Pathophysiology